Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914614248> ?p ?o ?g. }
- W2914614248 endingPage "750" @default.
- W2914614248 startingPage "737" @default.
- W2914614248 abstract "Introduction: Chronic obstructive pulmonary disease (COPD) therapy includes a multi-dimensional approach, taking into account both symptoms of the patient and the number of acute exacerbations of COPD (AECOPDs). There are three main pharmaceutical classes currently available including long-acting muscarinic antagonists (LAMA), long-acting β2-agonists (LABA) and inhaled corticosteroids (ICS). COPD is a major risk factor for most cardiovascular diseases, and cardiac comorbidities are very common in COPD patients. Both LAMA and LABA have a considerable impact on cardiac function by stimulating cardiac β2-adrenergic receptors or inhibiting the heart M2 muscarinic receptors. ICS alone or in combination has never been associated with a real cardiovascular risk.Areas covered: This review explores the data published on the safety of COPD therapy and the implications for current pharmacotherapy.Expert opinion: Several studies have confirmed the good safety profile of bronchodilators available both in monotherapy and in association with other bronchodilators of different classes or with ICS despite the device used. Cardiovascular events in clinical trials are generally low and balanced between groups. The actual cardiovascular risk of fixed-dose combinations (FDCs) in an unselected COPD population will need to be investigated through post-marketing surveillance studies and observational studies." @default.
- W2914614248 created "2019-02-21" @default.
- W2914614248 creator A5000054677 @default.
- W2914614248 creator A5013605540 @default.
- W2914614248 creator A5035810516 @default.
- W2914614248 creator A5053217610 @default.
- W2914614248 creator A5060089859 @default.
- W2914614248 creator A5062907116 @default.
- W2914614248 creator A5072493273 @default.
- W2914614248 date "2019-02-01" @default.
- W2914614248 modified "2023-09-25" @default.
- W2914614248 title "Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease" @default.
- W2914614248 cites W1165330509 @default.
- W2914614248 cites W1490958657 @default.
- W2914614248 cites W1768394073 @default.
- W2914614248 cites W1802331233 @default.
- W2914614248 cites W1877054624 @default.
- W2914614248 cites W1934734999 @default.
- W2914614248 cites W1963720710 @default.
- W2914614248 cites W1971310126 @default.
- W2914614248 cites W1974914274 @default.
- W2914614248 cites W1977759774 @default.
- W2914614248 cites W2003293665 @default.
- W2914614248 cites W2006528231 @default.
- W2914614248 cites W2009197337 @default.
- W2914614248 cites W2015963390 @default.
- W2914614248 cites W2023554430 @default.
- W2914614248 cites W2030987445 @default.
- W2914614248 cites W2032171019 @default.
- W2914614248 cites W2039237831 @default.
- W2914614248 cites W2053463673 @default.
- W2914614248 cites W2056040906 @default.
- W2914614248 cites W2057335633 @default.
- W2914614248 cites W2071738192 @default.
- W2914614248 cites W2072338852 @default.
- W2914614248 cites W2073362527 @default.
- W2914614248 cites W2075148927 @default.
- W2914614248 cites W2080929522 @default.
- W2914614248 cites W2086342579 @default.
- W2914614248 cites W2088477168 @default.
- W2914614248 cites W2089834473 @default.
- W2914614248 cites W2094495786 @default.
- W2914614248 cites W2097009791 @default.
- W2914614248 cites W2099529067 @default.
- W2914614248 cites W2109165189 @default.
- W2914614248 cites W2111722073 @default.
- W2914614248 cites W2111722183 @default.
- W2914614248 cites W2116505643 @default.
- W2914614248 cites W2116697960 @default.
- W2914614248 cites W2116894543 @default.
- W2914614248 cites W2117079401 @default.
- W2914614248 cites W2120356269 @default.
- W2914614248 cites W2123850585 @default.
- W2914614248 cites W2125065061 @default.
- W2914614248 cites W2125895372 @default.
- W2914614248 cites W2128278745 @default.
- W2914614248 cites W2128643475 @default.
- W2914614248 cites W2134091333 @default.
- W2914614248 cites W2134122420 @default.
- W2914614248 cites W2134820467 @default.
- W2914614248 cites W2141034778 @default.
- W2914614248 cites W2142449488 @default.
- W2914614248 cites W2142724633 @default.
- W2914614248 cites W2153441442 @default.
- W2914614248 cites W2161374186 @default.
- W2914614248 cites W2162627911 @default.
- W2914614248 cites W2162777271 @default.
- W2914614248 cites W2163317499 @default.
- W2914614248 cites W2164281047 @default.
- W2914614248 cites W2169393211 @default.
- W2914614248 cites W2169927995 @default.
- W2914614248 cites W2171952840 @default.
- W2914614248 cites W2171974515 @default.
- W2914614248 cites W2202024245 @default.
- W2914614248 cites W2233753101 @default.
- W2914614248 cites W2284395084 @default.
- W2914614248 cites W2305173708 @default.
- W2914614248 cites W2331317937 @default.
- W2914614248 cites W2344148139 @default.
- W2914614248 cites W2345974479 @default.
- W2914614248 cites W2346277111 @default.
- W2914614248 cites W2419159213 @default.
- W2914614248 cites W2427094903 @default.
- W2914614248 cites W2444083898 @default.
- W2914614248 cites W2487174795 @default.
- W2914614248 cites W2496257167 @default.
- W2914614248 cites W2512002633 @default.
- W2914614248 cites W2513086234 @default.
- W2914614248 cites W2544555580 @default.
- W2914614248 cites W2553006813 @default.
- W2914614248 cites W2558903543 @default.
- W2914614248 cites W2564473194 @default.
- W2914614248 cites W2567898942 @default.
- W2914614248 cites W2580357067 @default.
- W2914614248 cites W2588781854 @default.
- W2914614248 cites W2591678263 @default.
- W2914614248 cites W2604577460 @default.
- W2914614248 cites W2604743750 @default.